Advertisement
American Journal of Kidney Diseases

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

      Background

      Low urine potassium excretion, as a surrogate for dietary potassium intake, is associated with higher risk for hypertension and cardiovascular disease in a general population. Few studies have investigated the relationship of urine potassium with clinical outcomes in chronic kidney disease (CKD).

      Study Design

      Longitudinal cohort study.

      Setting & Participants

      The MDRD (Modification of Diet in Renal Disease) Study was a randomized controlled trial (N = 840) conducted in 1989 to 1993 to examine the effects of blood pressure control and dietary protein restriction on kidney disease progression in adults aged 18 to 70 years with CKD stages 2 to 4. This post hoc analysis included 812 participants.

      Predictor

      The primary predictor variable was 24-hour urine potassium excretion, measured at baseline and at multiple time points (presented as time-updated average urine potassium excretion).

      Outcomes

      Kidney failure, defined as initiation of dialysis therapy or transplantation, was determined from US Renal Data System data. All-cause mortality was assessed using the National Death Index.

      Results

      Median follow-up for kidney failure was 6.1 (IQR, 3.5-11.7) years, with 9 events/100 patient-years. Median all-cause mortality follow-up was 19.2 (IQR, 10.8-20.6) years, with 3 deaths/100 patient-years. Baseline mean urine potassium excretion was 2.39 ± 0.89 (SD) g/d. Each 1-SD higher baseline urine potassium level was associated with an adjusted HR of 0.95 (95% CI, 0.87-1.04) for kidney failure and 0.83 (95% CI, 0.74-0.94) for all-cause mortality. Results were consistent using time-updated average urine potassium measurements.

      Limitations

      Analyses were performed using urine potassium excretion as a surrogate for dietary potassium intake. Results are obtained from a primarily young, nondiabetic, and advanced CKD population and may not be generalizable to the general CKD population.

      Conclusions

      Higher urine potassium excretion was associated with lower risk for all-cause mortality, but not kidney failure.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lichtenstein A.H.
        • Appel L.J.
        • Brands M.
        • Carnethon M.
        • Daniels S.
        • et al.
        • American Heart Association Nutrition Committee
        Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee.
        Circulation. 2006; 114: 82-96
        • Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group
        KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
        Kidney Inter Suppl. 2012; 2: 337-414
        • Drewnowski A.
        • Rehm C.D.
        • Maillot M.
        • Mendoza A.
        • Monsivais P.
        The feasibility of meeting the WHO guidelines for sodium and potassium: a cross-national comparison study.
        BMJ Open. 2015; 5: e006625
        • National Kidney Foundation
        KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.
        Am J Kidney Dis. 2004; 43 (65-230)
        • No authors listed
        Chapter 2: lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients.
        Kidney Int Suppl. 2011; 2: 347-356
        • Kieneker L.M.
        • Gansevoort R.T.
        • Mukamal K.J.
        • et al.
        Urinary potassium excretion and risk of developing hypertension: the Prevention of Renal and Vascular End-Stage Disease Study.
        Hypertension. 2014; 64: 769-776
      1. Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr. 1997;65(2 suppl): 626S-642S.

        • Mente A.
        • O'Donnell M.J.
        • Rangarajan S.
        • et al.
        Association of urinary sodium and potassium excretion with blood pressure.
        N Engl J Med. 2014; 371: 601-611
        • O'Donnell M.
        • Mente A.
        • Rangarajan S.
        • et al.
        Urinary sodium and potassium excretion, mortality, and cardiovascular events.
        N Engl J Med. 2014; 371: 612-623
        • Aburto N.J.
        • Hanson S.
        • Gutierrez H.
        • Hooper L.
        • Elliott P.
        • Cappuccio F.P.
        Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses.
        BMJ. 2013; 346: f1378
        • Cook N.R.
        • Obarzanek E.
        • Cutler J.A.
        • et al.
        Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study.
        Arch Intern Med. 2009; 169: 32-40
        • Houston M.C.
        The importance of potassium in managing hypertension.
        Curr Hypertens Rep. 2011; 13: 309-317
        • Whelton P.K.
        • He J.
        • Cutler J.A.
        • et al.
        Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.
        JAMA. 1997; 277: 1624-1632
        • He F.J.
        • Marciniak M.
        • Carney C.
        • et al.
        Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives.
        Hypertension. 2010; 55: 681-688
        • Sharma S.
        • McFann K.
        • Chonchol M.
        • de Boer I.H.
        • Kendrick J.
        Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study.
        Am J Nephrol. 2013; 37: 526-533
        • Smyth A.
        • Dunkler D.
        • Gao P.
        • et al.
        The relationship between estimated sodium and potassium excretion and subsequent renal outcomes.
        Kidney Int. 2014; 86: 1205-1212
        • He J.
        • Mills K.T.
        • Appel L.J.
        • et al.
        Urinary sodium and potassium excretion and CKD progression.
        J Am Soc Nephrol. 2016; 27: 1202-1212
        • Araki S.
        • Haneda M.
        • Koya D.
        • et al.
        Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function.
        Clin J Am Soc Nephrol. 2015; 10: 2152-2158
        • Klahr S.
        • Levey A.S.
        • Beck G.J.
        • et al.
        The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
        N Engl J Med. 1994; 330: 877-884
        • Ix J.H.
        • Wassel C.L.
        • Stevens L.A.
        • et al.
        Equations to estimate creatinine excretion rate: the CKD Epidemiology Collaboration.
        Clin J Am Soc Nephrol. 2011; 6: 184-191
        • Peterson J.C.
        • Adler S.
        • Burkart J.M.
        • et al.
        Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
        Ann Intern Med. 1995; 123: 754-762
        • Adrogue H.J.
        • Madias N.E.
        Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension.
        J Am Soc Hypertens. 2014; 8: 203-213
        • Lin H.B.
        • Young D.B.
        • Smith Jr., M.J.
        Stimulation of renin release by hyperkalemia in the nonfiltering kidney.
        Am J Physiol. 1991; 260: F170-F176
        • Katori M.
        • Majima M.
        The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.
        Crit Rev Clin Lab Sci. 2003; 40: 43-115
        • Meneton P.
        • Jeunemaitre X.
        • de Wardener H.E.
        • MacGregor G.A.
        Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.
        Physiol Rev. 2005; 85: 679-715
        • Holbrook J.T.
        • Patterson K.Y.
        • Bodner J.E.
        • et al.
        Sodium and potassium intake and balance in adults consuming self-selected diets.
        Am J Clin Nutr. 1984; 40: 786-793
        • van Ypersele de Strihou C.
        Potassium homeostasis in renal failure.
        Kidney Int. 1977; 11: 491-504
        • Kopple J.D.
        • Coburn J.W.
        Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium.
        Medicine (Baltimore). 1973; 52: 583-595
        • Kahn T.
        • Kaji D.M.
        • Nicolis G.
        • Krakoff L.R.
        • Stein R.M.
        Factors related to potassium transport in chronic stable renal disease in man.
        Clin Sci Mol Med. 1978; 54: 661-666